Ratner, R E <br/><br/>
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Jul 2006 
 - 419-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1462-8902 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2006.00589.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Cardiovascular Diseases--etiology<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Exenatide<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Lipids--blood<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Overweight--drug effects<br/>Peptides--adverse effects<br/>Risk Factors<br/>Venoms--adverse effects<br/>Weight Loss--drug effects